Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q1 FY26 Earnings Presentation
22 slides from Valiant Organics's earnings presentation, Aug 20, 2025
Slide 1: Cover letter to stock exchanges: Investors' Presentation
August 20, 2025 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145
Slide 2: Earnings Presentation Q1-FY26
Earnings Presentation | Q1 -FY26
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket Q1-FY26 Revenue Share Hydrogenation Ammonolysis 53% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q1-FY26 Highlights
Q1-FY26 HIGHLIGHTS Valiant Organics Limited | Q1-2026 7
Slide 9: Q1-FY26 Consolidated Financial Highlights
Q1-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,044 Mn Operational Revenue INR 248 Mn Operating EBITDA 12.13 % Operating EBITDA Margin INR 82 Mn Profit After Tax 4.01 % PAT Margin INR 2.93/ Share EPS Valiant Organics Limited | Q1-2026 8
Slide 10: Q1 FY26 Operational Highlights
Q1 FY26 Operational Highlights Q1-FY26 Revenue Break-up – Chemistries • Revenue remained steady sequentially and showed strong year-on-year Others, 5% growth, supported by higher sales volumes and better realizations. Chlorination, • Gross Profit rose to INR 797 millions, up 11% Q-o-Q and 20% Y-o-Y,
Slide 11: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1200 1,126 1,082 560 543 140 118 450 413 394 1000 540 REVENUES 120 94 400 327 520 660 350 100 800 500 475 300 80 600 458 250 480 200 400 460 60 42 150 40 440 100 200 20 420 50 400 0 0 0 Q1-FY25 Q4-FY25
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q1-FY26 Q1-FY25 Y-o-Y Q4-FY25 Q-o-Q Revenue from Operations 2,044 1,679 21.7% 2,038 0.3% Total Expenses 1,796 1,522 18.0% 1,835 (2.1)% EBITDA 248 157 58.0% 203 22.2% EBITDA Margins (%) 12.13% 9.35% 278 Bps 9.96% 217 Bps Other Income 1
Slide 13: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q1-FY26 Q1-FY25 Y-o-Y Q4-FY25 Q-o-Q Revenue from Operations 2,044 1,679 21.7% 2,038 0.3% Total Expenses 1,796 1,522 18.0% 1,835 (2.1)% EBITDA 248 157 58.0% 203 22.2% EBITDA Margins (%) 12.13% 9.35% 278 Bps 9.96% 217 Bps Other Income 11
Slide 14: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q1-2026 13
Slide 15: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY23 FY24 FY25 Q1-FY26 Revenue from Operations 10,518 7,231 7,188 2,044 Total Expenses 8,875 6,849 6,651 1,796 EBITDA 1,643 382 537 248 EBITDA Margins (%) 15.62% 5.28% 7.47% 12.13% Other Income 80 93 86 11 Depreciation 292 349 358 94 Fina
Slide 16: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY23 FY24 FY25 Particulars (INR Mn) FY23 FY24 FY25 EQUITY 7,401 7,293 7,253 Non-Current Assets 7,682 8,352 8,269 a) Equity Share Capital 272 276 280 a) Property, Plant and Equipment 6,565 6,297 6,437 b) Other Equity 6,616 7,017 6,973 c) Righ
Slide 17: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY23 FY24 FY25 Q1-FY26 Revenue from Operations 9,116 6,772 7,188 2,044 Total Expenses 7,817 6,376 6,651 1,796 EBITDA 1,299 396 537 248 EBITDA Margins (%) 14.25% 5.85% 7.47% 12.13% Other Income 29 29 81 11 Depreciation 276 340 358 94 Finance
Slide 18: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Particulars (INR Mn) FY23 FY24 FY25 Particulars (INR Mn) FY23 FY24 FY25 EQUITY 6,661 6,649 6,616 Non-Current Assets 7,424 7,818 7,750 a) Equity Share Capital 272 276 280 a) Property, Plant and Equipment 6,092 6,297 6,437 b) Other Equity 6,385 6,373 6,336 b) Right-
Slide 19: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 1,400 10,518 10,000 1,643 1,100 1,026 17.00% 7,500 7,231 7,188 9.75% 800 12.00% 5,000 537 500 15.62% 2,044 382 7.00% 2,500 248 82 5.28% 7.47% 12.13% 200 4.01% - 2.00% -1
Slide 20: Capital Market Information
Capital Market Information Share Price up to 30th June, 2025 30% 10% -10% -30% -50% -70% Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Valiant Organics Sensex Price Data (As of 30th June, 2025) INR Shareholding pattern (As of 30th June, 2025) FII; 0.21% DII; 0.0
Slide 21: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 22: Thank You
THANK YOU Valiant Organics Limited | Q1-2026 21